Latest / Applied Clinical Trials
The Oncologist:Patient Conversation Must Include Clinical Trials
Dr. Shalaan Beg, VP of Oncology for Science 37, discusses his approach to reducing the time to trial activation at an NCI designated cancer center, how to ensure a diverse representation in clinical trials, and his opinion on decentralized and hybrid trials.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.